Sore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open Ophthalmology, which calls for a change in the way symptoms are classified.
Researchers at Anglia Ruskin University in Cambridge, England, asked people who had a confirmed COVID-19 diagnosis to complete a questionnaire about their symptoms, and how those compared to before they tested positive.
The study found sore eyes was significantly more common when the participants had COVID-19, with 16% reporting the issue as one of their symptoms, according to Science Daily. As few as 5% reported having had the condition beforehand.
Of the 83 respondents, 81% reported ocular issues within two weeks of other COVID-19 symptoms, and of those, 80% reported their eye problems lasted less than two weeks.
The most common reported symptoms overall were fatigue (suffered by 90% of respondents), a fever (76%) and a dry cough (66%).
Lead author Professor Shahina Pardhan, director of the university’s Vision and Eye Research Institute, said this was the first study of its kind.
“This is the first study to investigate the various eye symptoms indicative of conjunctivitis in relation to COVID-19, their time frame in relation to other well-known COVID-19 symptoms and their duration,” Pardhan said.
“While it is important that ocular symptoms are included in the list of possible COVID-19 symptoms, we argue that sore eyes should replace ‘conjunctivitis’ as it is important to differentiate from symptoms of other types of infections, such as bacterial infections, which manifest as mucous discharge or gritty eyes.”
Pardhan underlined the relevance of the research findings.
“This study is important because it helps us understand more about how COVID-19 can infect the conjunctiva and how this then allows the virus to spread through the body.”
More reading
Phaco and surgeon contamination risks amid COVID-19
AMD patients at higher risk of COVID-19 death
COVID-19 detected after eye exams of asymptomatic patients
Cornea resistant to the novel coronavirus – study
